As six-year-old tech unicorn PharmEasy acquires publicly-listed diagnostics chain Thyrocare, many believe it is a pivotal moment for startups in India CEO Siddharth Shah says the strong bond ...

Almost all of these have heavy discounts for basic tests, which PharmEasy has to match to keep up pace, said one Thyrocare franchise owner based in Kalyan, near Mumbai. Lately, PharmEasy has ...

PharmEasy plans to raise ₹ 6,250 crore through its public issue. The company will use this capital to acquire new businesses and repay loans. Its consolidated revenue tripled to ₹2360 crore in ...